|
|
 |
|
Viewing report
|
|
|
|
Animal Pharms Top 20: 2006 Edition
Informa Healthcare, Jan 2006, Pages: 283
Animal Pharm’s Top 20 is recognised throughout the animal health and nutrition industry as a key source of information and analysis on the 20 largest companies in the sector. Invest in this report to keep informed of the performance of your potential competitors, collaborators or customers.
Key Findings:
- Global sales of animal health and nutrition products totalled almost US$21.7 billion in 2005. That figure was around 7% higher than the year-earlier total of US$20.3 billion.
- Sales of veterinary pharmaceuticals and biologicals for use in small animals alone are now worth almost US$6 billion, a figure equivalent to more than 27% of the entire market.
- The 13% increase in revenues reported by Pfizer Animal Health in 2005 saw the company consolidate its position at the head of the global sales league, with a gap of more than US$200 million between it and second-placed Merial.
- Merial appears set to leapfrog Pfizer in 2006, regaining the leadership position it held prior to Pfizer’s acquisition of Pharmacia Corp in 2003.
- The acquisition of Adisseo by the China National Chemical Corp (CNCC), announced late in 2005 and completed in 2006, is among the most significant M&A developments reported recently in the industry.
- Despite SPAH’s recent problems in the US market, most recent results indicate that the worst may finally be behind the company, with US sales up sharply on year-earlier figures in the first half of 2006.
- Merial’s Frontline sales fell back by 11% on year-earlier figures in the third quarter of 2005. That was followed by a 31% gain in the final quarter, however, and further strong growth through the first half of 2006.
This report profiles the businesses of 20 leading companies that generate aggregate annual revenues equivalent in value to more than three-quarters of global animal health and nutrition product sales. Each profile analyses the background of the company concerned, and examines in detail the size, structure and recent performance of its animal health business. Information on individual company strategies, R&D pipelines and future performance prospects is also provided.
Information sources used to compile the report include the Informa newsletter, Animal Pharm World Animal Health and Nutrition News; a range of other trade press sources; corporate web sites, annual reports, presentations and other publications; and contacts within the industry or at individual companies.
The structure of the world animal health and nutrition products market is discussed in an introductory section, which includes tabulated company sales rankings for 2005 and ranking forecasts for 2006. It also includes an analysis of profit levels being generated by leading companies in the sector. Data included in the latter section indicates that pre-tax margins towards the top end of the industry currently average a little over 18%. Among the companies that publish earnings data for their animal health businesses, Eli Lillys Elanco subsidiary is the most profitable, posting an operating margin of just under 25% in 2005.
Aggregate sales generated by the 20 market leaders rose by a little over 7% to almost US$16.3 billion in 2005. Early indications are that a similar increase will be posted in 2006, but individual performances will again vary widely. Perhaps most significantly, Merial appears to be on track to displace Pfizer at the head of the industry sales league during 2006, having booked a sales gain of more than 16% in the first half of the year. Merial is one of six companies expected to report a double-digit increase in revenues this year. Two of the industrys three biggest businesses - Pfizer and Intervet - will post low single-figure gains, however, and aggregate sales of the 20 market leaders are forecast to rise by a little over 7% once again.
Customers who bought this item also bought
Veterinary Vaccines - Global Strategic Business Report
Veterinary Health Markets
Animal Pharms Top Tier Companies: 2007 Edition
Animal Health Products Antibacterials Markets
Global Animal Health Market Report: 2010 Edition
Global Animal Health Market Report: 2011 Edition
Veterinary Vaccines - A World Market Analysis
Global Animal Health Market: Emerging Markets Driving Growth
European Animal Health Markets & Opportunities
Top 200 Animal Health Report (Global)
|
|
|
|
